Evidence map›Paper›PMID 29940897›Full record

Observational studyBMC psychiatry2018

The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system.

Susan Young, Rafael A González, Moshe Fridman, Paul Hodgkins, Keira Kim, Gisli H Gudjonsson

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The need for speed? Exploring the risks and benefits of pharmacological treatment for adult ADHD in prisons.Psychiatry, psychology, and law : an interdisciplinary journal of the Australian and New Zealand Association of Psychiatry, Psychology and Law · 2024
    Article
  6. Article
  7. ADHD and offending.Journal of neural transmission (Vienna, Austria : 1996) · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Susan YoungPsychology Services Limited, PO Box 1735, Croydon, CR97AE, UK. suzyyoung@aol.com.ORCID 0000-0002-8494-6949
Rafael A GonzálezEast London NHS Foundation Trust, London, UK.
Moshe FridmanAMF Consulting Inc, Los Angeles, CA, USA.
Paul HodgkinsSage Therapeutics, Cambridge, MA, USA.
Keira KimIndedpendent Medical Writer, San Diego, CA, USA.
Gisli H GudjonssonReykjavik University, Reykjavik, Iceland.
Reykjavík University · ISDepomed (United States) · USEast London NHS Foundation Trust · GBSage Therapeutics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAttention-deficit hyperactivity disorder (ADHD) is highly prevalent amongst prison inmates and the criminal justice system (CJS) likely bears considerable costs for offenders with ADHD. We aimed to examine the relationship between ADHD and health-related quality of life (HRQoL) and quality-adjusted life years (QALY) amongst imprisoned adults; and to estimate the annual expenditure associated with ADHD status in prison.

methodsAn observational study was performed in 2011-2013, at Porterfield Prison, Inverness, United Kingdom (UK). The all male sample included 390 adult prison inmates with capacity to consent and no history of moderate or severe intellectual disability. Participants were interviewed using the Diagnostic Interview for ADHD in Adults 2.0. The Health Utilities Index Mark 3 (HUI3) was used to measure health status, and to calculate attribute specific HRQoL scores and QALY. Health service utilisation was obtained through inspection of medical prison records. Inmates with ADHD were compared with inmates without ADHD.

resultsInmates with ADHD had significantly lower QALYs, with a clinically significant adjusted difference of 0.13. Psychiatric co-morbidity accounted for the variation of ADHD on the HUI3 emotion domain only. Medical costs for inmates with ADHD were significantly higher; and behaviour-related prison costs were similar to prisoners without ADHD, reflecting a low frequency of recorded critical incidents.

conclusionsADHD may directly contribute to adverse health and quality of life through cognitive and executive function deficits, and co-morbid disorders. The extrapolation of conservative cost estimates suggests that the financial burden of medical and behavior-related prison care for inmates with ADHD in the UK is approximately £11.7 million annually. The reported cost estimates are conservative as there is great variability in recorded critical incidents in prisons. In turn, for some prison establishments the prison care costs associated with prisoners with ADHD may be considerably greater.

Indexed as

AdultAttention Deficit Disorder with HyperactivityComorbidityExecutive FunctionHumansIntellectual DisabilityMalePrevalencePrisonersPrisonsPsychiatric Status Rating ScalesQuality of LifeScotlandYoung AdultADHDCostsEconomic evaluationHealth-related quality of lifePrisonQuality-adjusted life years

Identifiers

PMID29940897
PMCPMC6019793
OpenAlexW2809453065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.